Andera Partners — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Cyllene Therapeuticscyllene-tx.comSeries B · Jul 2026 · $28M
Cyllene Therapeutics is a biotechnology company developing "pinpoint gene therapy" using a non-replicative HSV-1 based vector platform to deliver disease-modifying transgenes for peripheral nervous system disorders.
BiotechDeep TechDigital HealthParis, FR
Philippe Chambon MD, PhD(Founder)inPhilippe Chambon(Founder, Chairman & CEO)Alberto Epstein(Founder & CSO)Cornelia Haag-Molkenteller(CMO)Samuel Salot(COO)Marc Grasso(CFO)
Co-investorsBpifranceM VenturesSCI Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.